Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheuma...
| الحاوية / القاعدة: | Научно-практическая ревматология |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
IMA PRESS LLC
2012-08-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://rsp.mediar-press.net/rsp/article/view/1032 |